Histopathologic And Clinical Features of Bethesda III-VI Nodules Harboring Isolated RAS Mutations

By sjmartinez • December 9, 2024

Seo YJ, Huston-Paterson HH, Schumm MA, Longstaff XR, Hughes EG, Tseng CH, Cheung DS, Yeh MW, Wu JX, Livhits MJ. Histopathologic And Clinical Features of Bethesda III-VI Nodules Harboring Isolated RAS Mutations. Endocr Pract. 2024 Dec 6:S1530-891X(24)00857-7. doi: 10.1016/j.eprac.2024.12.001. Epub ahead of print. PMID: 39647526.

Tags: BRAF V600E, Endocrinology, General Internal Medicine, molecular testing, Publications, RAS, recurrence, thyroid cancer

The ULK1-NCOA3 axis restrains de novo lipogenesis and prevents diet-induced steatohepatitis and fibrosis in mice

Koo YD, Castillo RT, Sukumaran Nair A, Garneau M, Gochee C, Campbell ZV, Vakil TS, Ha J, Marti A, Soto J, Das D, Martinez-Lopez N,[...]

Omitting Radioactive Iodine after Therapeutic Lateral Neck Dissection May Be the Next Step in De-Escalating Initial Treatment of Papillary Thyroid Cancer

Yeh MW. Omitting Radioactive Iodine after Therapeutic Lateral Neck Dissection May Be the Next Step in De-Escalating Initial Treatment of Papillary Thyroid Cancer. Thyroid. 2026[...]

Knowledge of Interpreter Rights and Medication Delays in Diabetes Care

Linares MA, Everett EM, Rodriguez JA, Casillas A, Brown A. Knowledge of Interpreter Rights and Medication Delays in Diabetes Care. J Immigr Minor Health. 2026[...]